康复新液联合雷贝拉唑治疗酒精相关性胃粘膜损伤的临床效果  

The clinical effect of new recovery liquid combined with rabeprazole on treating alcohol correlation mucous membrane

作　　者：李颖[1] 何小勤[1] 易默[1] 金燕[1] 

机构地区：[1]陕西省人民医院,西安710068

出　　处：《湖南师范大学学报（医学版）》2015年第4期67-68,69,共3页Journal of Hunan Normal University(Medical Sciences)

摘　　要：目的 :通过对酒精相关性胃粘膜损伤患者采取康复新液联合雷贝拉唑治疗的方法,探究这种疗法的临床疗效。方法 :从2013年3月~2014年12月期间在我院进行治疗的酒精相关性胃粘膜损伤的患者中随机抽出100名平均分为两组,实验组患者采取康复新液联合雷贝拉唑进行治疗,对照组患者仅采取雷贝拉唑进行治疗,比较经过一段时间治疗后两组患者症状改善率以及治疗后胃镜复查胃黏膜改善率情况的比较。结果 :经过一段时间的治疗,实验组患者症状的改善率明显优于对照组患者,同时胃镜复查胃粘膜改善率也超过对照组患者,数据的比较均可以得到P<0.05,差异在统计学上有意义。结论 :对于酒精相关性胃黏膜损伤的治疗,康复新液联合雷贝拉唑的疗法比较雷贝拉唑单独疗法来说,能够更好、更快的起到缓解患者症状、改善损伤的胃粘膜的目的,具有明显的疗效且治疗的不良反较轻。Objective To explore the clinical effect of new recovery liquid combined with rabeprazole on treating alcohol correlation mucous membrane through this two methods on patients. Method Selected 100 patients who treated alcohol correlation mucous membrane from March 2013 to December 2014 in our hospital, they were divided into two groups equally, test group used Fuxinkangye combined with rabeprazole, test group only used rabeprazole, compared the improvement rate of symptoms and improvement of gastric mucosa under gastroscope of two groups. Result After treatment, the improvement rate of symptoms in test group was obvious better than control group as well as the improvement of gastric mucosa under gastroscope, all P<0.05, with statistical significance. Conclusion Compared with single rabeprazole, new recovery liquid combined with rabeprazole on treating alcohol correlation mucous membrane can release patients' symptoms, improve the gastric mucosa and has obvious curative effect and low adverse reactions.

关 键 词：康复新液 联合 雷贝拉唑 酒精相关性胃粘膜损伤 临床效果 

分 类 号：R573.1[医药卫生—消化系统]